Geneva, April 28 -- International Clinical Trials Registry received information related to the study (ChiCTR2600122442) titled 'A Study on Intelligent Diagnostic and Therapeutic Evaluation for Malignant Tumors and Neurodegenerative Diseases Based on One-Day Dual-Tracer Whole-Body PET/CT Imaging' on April 14.
Study Type: Observational study
Study Design:
Cross-sectional
Primary Sponsor: Department of Nuclear Medicine, The First Medical Center of PLA General Hospital
Condition:
Pancreatic cancer, prostate cancer, Parkinson's syndrome, Alzheimers disease
Intervention:
Patients initially suspected of or diagnosed with pancreatic cancer:None
Patients suspected of or diagnosed with prostate cancer for the first time:None
Patient suspe...